FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA | contraceptive | Regulators | FDA approval | Plan B

Report: Crawford wouldn't cooperate in Plan B investigation

Tools

A draft copy of a General Accounting Office report on the FDA's handling of the decision on the morning-after contraceptive Plan B indicates that former FDA commissioner Lester Crawford refused to answer any of its questions in the probe, according to The Washington Post. Plan B's advocates say the report makes clear that political considerations dictated the FDA's announcement that it would delay any final decision on the drug, leaving it in limbo. Conservatives had fiercely opposed the drug, which was endorsed by an expert panel at the FDA, saying that it would encourage teen promiscuity.

- read this article from The Washington Post for more


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about FDA   contraceptive   Regulators   FDA approval   Plan B